{
  "title": "Division of Corporation Finance Statement Regarding Submission of Supplemental Materials and Information Subject to Rule 83 Confidential Treatment Requests in Light of COVID-19 Concerns",
  "link": "https://www.sec.gov/corpfin/announcement/supplemental-materials-covid-19-concerns",
  "description": "Submission of Supplemental Materials and Information Subject to Rule 83 Confidential Treatment Requests in Light of COVID-19 Concerns",
  "guid": "supplemental-materials-covid-19-concerns",
  "category": "Announcement",
  "pubDate": "Tue, 4 Aug 2020 10:15:00 EDT"
}